For instance, treatment with Parnate, an enzymatic inhibitor of LSD1, or TAT-SNAG, a cell-permeable peptide corresponding to the SNAG domain of Slug, blocks the Snail/Slug-LSD1 interaction and suppresses the motility and invasiveness of cancer cells of different origins and genetic background (Ferrari-Amorotti et al., 2013). This evidence concerns the gene KDM1A and cancer.